T S Maughan
Overview
Explore the profile of T S Maughan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Graham J, Boyd K, Coxon F, Wall L, Eatock M, Maughan T, et al.
BMC Res Notes
. 2016 Mar;
9:161.
PMID: 26969121
Background: Advanced biliary tract carcinomas are associated with a poor prognosis, and palliative chemotherapy has only modest benefit. This multi-centre phase II study was conducted to determine the efficacy of...
3.
Biswas S, Holyoake D, Maughan T
Clin Oncol (R Coll Radiol)
. 2015 Dec;
28(2):73-82.
PMID: 26631427
Over the last 5 years there has been a surge in interest in the molecular classification of colorectal cancer. The effect of molecular subtyping on current treatment decisions is limited...
4.
Maughan T, Meade A, Adams R, Richman S, Butler R, Fisher D, et al.
Br J Cancer
. 2014 Apr;
110(9):2178-86.
PMID: 24743706
Background: Molecular characteristics of cancer vary between individuals. In future, most trials will require assessment of biomarkers to allocate patients into enriched populations in which targeted therapies are more likely...
5.
Madi A, Fisher D, Wilson R, Adams R, Meade A, Kenny S, et al.
Br J Cancer
. 2012 Sep;
107(7):1037-43.
PMID: 22935584
Background: COIN compared first-line continuous chemotherapy with the same chemotherapy given intermittently or with cetuximab in advanced colorectal cancer (aCRC). Methods: Choice between oxaliplatin/capecitabine (OxCap) and oxaliplatin/leucovorin (LV)/infusional 5-FU (OxFU)...
6.
Burnet N, Billingham L, Chan C, Hall E, MacDougall J, Mackay R, et al.
Clin Oncol (R Coll Radiol)
. 2012 Jul;
24(10):707-9.
PMID: 22795231
No abstract available.
7.
Shaw P, Maughan T, Clarke A
Br J Cancer
. 2011 Aug;
105(5):649-57.
PMID: 21811251
Background: Identification of early molecular pathway changes may be useful as biomarkers for tumour response/resistance prediction, and here we provide direct in vivo proof of this concept. The type 1...
8.
Harrington K, Billingham L, Brunner T, Burnet N, Chan C, Hoskin P, et al.
Br J Cancer
. 2011 Jul;
105(5):628-39.
PMID: 21772330
No abstract available.
9.
Maughan T, Illidge T, Hoskin P, McKenna W, Brunner T, Stratford I, et al.
Clin Oncol (R Coll Radiol)
. 2010 Apr;
22(8):707-9.
PMID: 20363111
No abstract available.
10.
Clements D, Dhruva Rao P, Ramanathan D, Adams R, Maughan T, Davies M
Colorectal Dis
. 2009 Jan;
11(8):845-8.
PMID: 19175637
Objective: The management of the asymptomatic primary in stage IV colorectal cancer presents a dilemma. There is an increased morbidity and mortality from surgical resection. Nonresectional management of the primary...